NCT00157690 Study of Alendronate to Prevent and Treat Osteoporosis in Cystic Fibrosis Patients Status COMPLETED Phase PHASE4
NCT00157183 Non-invasive Ventilation and Oxygen Therapy in Cystic Fibrosis Patients With Nocturnal Oxygen Desaturation Status COMPLETED Phase PHASE1/PHASE2
NCT00153634 Standard vs. Biofilm Susceptibility Testing in Cystic Fibrosis (CF) Status COMPLETED Phase NA
NCT00130182 A Study in Pediatric Patients With Cystic Fibrosis Lung Disease Status COMPLETED Phase PHASE2
NCT00129350 Assessment of Heart and Heart-Lung Transplant Patient Outcomes Following Pulmonary Rehabilitation Status UNKNOWN Phase PHASE1
NCT00128492 Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis (CF) Patients With Pseudomonas Aeruginosa (PA) Status COMPLETED Phase PHASE3
NCT00125346 Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis Subjects Status TERMINATED Phase PHASE3
NCT00117208 Comparison of Inhaled Mannitol and rhDNase in Children With Cystic Fibrosis Status COMPLETED Phase PHASE2
NCT00112359 International Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa Status COMPLETED Phase PHASE3
NCT00105183 EZ-2053 in the Prophylaxis of Acute Pulmonary Allograft Rejection Status COMPLETED Phase PHASE3
NCT00104520 Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa Status COMPLETED Phase PHASE3
NCT00104494 Zinc Homeostasis and Kinetics in Children With Cystic Fibrosis (CF) Status COMPLETED Phase NA
NCT00103714 Study of Denufosol Tetrasodium in Patients With Cystic Fibrosis Lung Disease Status COMPLETED Phase PHASE2
NCT00097773 Comparison of Two Treatment Regimens to Reduce PA Infection in Children With Cystic Fibrosis Status COMPLETED Phase PHASE2
NCT00095732 Oral TheraCLECâ„¢ - Total in Cystic Fibrosis Subjects With Exocrine Pancreatic Insufficiency Status COMPLETED Phase PHASE2
NCT00082238 Increased Gluconeogenesis is One Cause of Cystic Fibrosis Related Diabetes (CFRD) Status COMPLETED Phase NA
NCT00079742 A Study to Evaluate Nutropin AQ for the Treatment of Growth Restriction in Children With Cystic Fibrosis Status COMPLETED Phase PHASE2
NCT00073463 Safety and Efficacy of Recombinant Adeno-Associated Virus Containing the CFTR Gene in the Treatment of Cystic Fibrosis Status TERMINATED Phase PHASE2/PHASE3
NCT00060801 Efficacy and Safety of 24 Weeks of Oral Treatment With BIIL 284 BS in Adult and Pediatric Patients Status TERMINATED Phase PHASE2